Literature DB >> 27998839

FFR result post PCI is suboptimal in long diffuse coronary artery disease.

Arvydas Baranauskas1, Aaron Peace, Aleksandras Kibarskis, Joanne Shannon, Vytautas Abraitis, Vilhelmas Bajoras, Valdas Bilkis, Audrius Aidietis, Aleksandras Laucevicius, Giedrius Davidavicius.   

Abstract

AIMS: The aim of this study was to evaluate the functional result immediately post PCI and at nine-month follow-up, and to ascertain how often a functionally optimal result of >0.95 can be achieved in long coronary lesions treated with long second- or newer-generation DES. METHODS AND
RESULTS: Patients receiving DES measuring ≥30 mm with FFR value ≤0.8 were included in the study. Stent length was defined as long (30 to 49 mm; L-DES) and ultra-long (≥50 mm; UL-DES). Angiographic and FFR evaluation was performed before and after PCI and at nine-month follow-up. A total of 74 patients each received a mean stent length of 50.72±14.6 mm. Mean FFR post PCI was 0.88±0.06. An optimal post PCI FFR value of >0.95 was achieved in only 9/74 patients (12.2%), and was not achieved in any UL-DES patients. Only 12/74 (16.2%) had FFR post PCI of 0.91 to 0.95; 8/74 (10.8%) patients remained ischaemic (≤0.8). FFR gradient across the stent was higher in UL-DES patients compared to L-DES patients (0.07±0.03 vs. 0.04±0.03; p=0.001). At follow-up, the angiographic restenosis rate was 4.7%, and the functional restenosis rate was 15.1%.
CONCLUSIONS: The FFR result post PCI was suboptimal in the majority of patients treated with long DES and was particularly poor when the total stent length exceeded 50 mm.

Entities:  

Mesh:

Year:  2016        PMID: 27998839     DOI: 10.4244/EIJ-D-15-00514

Source DB:  PubMed          Journal:  EuroIntervention        ISSN: 1774-024X            Impact factor:   6.534


  6 in total

Review 1.  The Clinical Significance of Physiological Assessment of Residual Ischemia After Percutaneous Coronary Intervention.

Authors:  Chandra P Ojha; Ahmed Ibrahim; Timir K Paul; Venkatachalam Mulukutla; Harsha S Nagarajarao
Journal:  Curr Cardiol Rep       Date:  2020-02-08       Impact factor: 2.931

Review 2.  Coronary CT Angiography to Guide Percutaneous Coronary Intervention.

Authors:  Georgios Tzimas; Gaurav S Gulsin; Hidenobu Takagi; Niya Mileva; Jeroen Sonck; Olivier Muller; Jonathon A Leipsic; Carlos Collet
Journal:  Radiol Cardiothorac Imaging       Date:  2022-01-06

3.  A randomized controlled trial of a physiology-guided percutaneous coronary intervention optimization strategy: Rationale and design of the TARGET FFR study.

Authors:  Damien Collison; John D McClure; Colin Berry; Keith G Oldroyd
Journal:  Clin Cardiol       Date:  2020-02-10       Impact factor: 2.882

4.  Physiological Pattern of Disease Assessed by Pressure-Wire Pullback Has an Influence on Fractional Flow Reserve/Instantaneous Wave-Free Ratio Discordance.

Authors:  Takayuki Warisawa; Christopher M Cook; James P Howard; Yousif Ahmad; Shunichi Doi; Masafumi Nakayama; Sonoka Goto; Yohei Yakuta; Kenichi Karube; Matthew J Shun-Shin; Ricardo Petraco; Sayan Sen; Sukhjinder Nijjer; Rasha Al Lamee; Yuki Ishibashi; Hisao Matsuda; Javier Escaned; Carlo di Mario; Darrel P Francis; Yoshihiro J Akashi; Justin E Davies
Journal:  Circ Cardiovasc Interv       Date:  2019-05       Impact factor: 6.546

5.  Impact of Poststenting Fractional Flow Reserve on Long-Term Clinical Outcomes: The FFR-SEARCH Study.

Authors:  Roberto Diletti; Kaneshka Masdjedi; Joost Daemen; Laurens J C van Zandvoort; Tara Neleman; Jeroen Wilschut; Wijnand K Den Dekker; Rutger J van Bommel; Miguel Lemmert; Isabella Kardys; Paul Cummins; Peter de Jaegere; Felix Zijlstra; Nicolas M Van Mieghem
Journal:  Circ Cardiovasc Interv       Date:  2021-03-09       Impact factor: 6.546

6.  Post-stenting fractional flow reserve vs coronary angiography for optimization of percutaneous coronary intervention (TARGET-FFR).

Authors:  Damien Collison; Matthaios Didagelos; Muhammad Aetesam-Ur-Rahman; Samuel Copt; Robert McDade; Peter McCartney; Thomas J Ford; John McClure; Mitchell Lindsay; Aadil Shaukat; Paul Rocchiccioli; Richard Brogan; Stuart Watkins; Margaret McEntegart; Richard Good; Keith Robertson; Patrick O'Boyle; Andrew Davie; Adnan Khan; Stuart Hood; Hany Eteiba; Colin Berry; Keith G Oldroyd
Journal:  Eur Heart J       Date:  2021-12-01       Impact factor: 29.983

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.